A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy
Public ClinicalTrials.gov record NCT00067782. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to learn if atazanavir is associated with serum LDL cholesterol in HIV-infected subjects following a substitution of atazanavir for their previously administered protease inhibitor.
Study identification
- NCT ID
- NCT00067782
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2002 (Type not available)
- Primary completion
- Mar 2005 (Actual)
- Completion
- Mar 2005 (Actual)
- Last update posted
- Apr 14, 2011
2002 – 2005
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Phoenix | Arizona | — | — |
| Local Institution | West Hollywood | California | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Altamonte Springs | Florida | — | — |
| Local Institution | Fort Lauderdale | Florida | — | — |
| Local Institution | Miami | Florida | — | — |
| Local Institution | Tampa | Florida | — | — |
| Local Institution | Boston | Massachusetts | — | — |
| Local Institution | Minneapolis | Minnesota | — | — |
| Local Institution | St Louis | Missouri | — | — |
| Local Institution | East Orange | New Jersey | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Huntersville | North Carolina | — | — |
| Local Institution | Cleveland | Ohio | — | — |
| Local Institution | Oklahoma City | Oklahoma | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Columbia | South Carolina | — | — |
| Local Institution | Fort Worth | Texas | — | — |
| Local Institution | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00067782, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2011 · Synced Oct 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00067782 live on ClinicalTrials.gov.